Clinical Trial

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

Name: Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia — clinical trial record (NCT07073014)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CANOPY-HCH-EXT

Enrolling by Invitation Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the long-term safety and efficacy of daily doses of vosoritide in participants with HCH

Trial Details

NCT Number	NCT07073014
Lead Sponsor	BioMarin Pharmaceutical
Conditions	Hypochondroplasia
Enrollment	140 participants
Start Date	2025-06-20
Primary Completion	2040-12 (estimated)
Study Completion	2040-12 (estimated)
Updated on ClinicalTrials.gov	2025-07-18